Hortobagyi GN - Search Results

1

A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer.

Moulder SL, Holmes FA, Tolcher AW, Thall P, Broglio K, Valero V, Buzdar AU, Arbuck SG, Seidman A, Hortobagyi GN. Moulder SL, et al. Among authors: hortobagyi gn. Cancer. 2010 Feb 15;116(4):814-21. doi: 10.1002/cncr.24870. Cancer. 2010. PMID: 20052721 Free PMC article. Clinical Trial.

2

Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma.

Krutchik AN, Buzdar AU, Blumenschein GR, Hortobagyi GN, Tashima CK, Gutterman JU, Yap HY, Hersh EM. Krutchik AN, et al. Among authors: hortobagyi gn. J Surg Oncol. 1979;11(4):325-32. doi: 10.1002/jso.2930110407. J Surg Oncol. 1979. PMID: 109703

3

Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma.

Legha SS, Buzdar AU, Hortobagyi GN, DiStefano A, Wiseman CL, Yap HY, Blumenschein GR, Bodey GP. Legha SS, et al. Among authors: hortobagyi gn. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2053-6. Cancer Treat Rep. 1979. PMID: 118805 Clinical Trial.

4

Hormonal therapy with tamoxifen in male breast cancer.

Hortobagyi GN, DiStefano A, Legha SS, Buzdar AU, Blumenschein GR. Hortobagyi GN, et al. Cancer Treat Rep. 1979 Apr;63(4):539-41. Cancer Treat Rep. 1979. PMID: 221118 No abstract available.

5

Combination chemotherapy with vincristine and methotrexate for advanced refractory breast cancer.

Yap HY, Blumenschein GR, Tashima CK, Hortobagyi GN, Buzdar AU, Wiseman CL. Yap HY, et al. Among authors: hortobagyi gn. Cancer. 1979 Jul;44(1):32-4. doi: 10.1002/1097-0142(197907)44:1<32::aid-cncr2820440106>3.0.co;2-3. Cancer. 1979. PMID: 222433

6

Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.

Yap HY, Salem P, Hortobagyi GN, Bodey GP Sr, Buzdar AU, Tashima CK, Blumenschein GR. Yap HY, et al. Among authors: hortobagyi gn. Cancer Treat Rep. 1978 Mar;62(3):405-8. Cancer Treat Rep. 1978. PMID: 348308 Clinical Trial.

7

Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.

Buzdar AU, Legha SS, Tashima CK, Yap HY, Hortobagyi GN, Hersh EM, Blumenschein GR, Bodey GP. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer Treat Rep. 1979 Jan;63(1):115-20. Cancer Treat Rep. 1979. PMID: 369682 Clinical Trial.

8

Rubidazone in metastatic breast cancer.

Legha SS, Benjamin RS, Buzdar AU, Hortobagyi GN, Blumenschein GR. Legha SS, et al. Among authors: hortobagyi gn. Cancer Treat Rep. 1979 Jan;63(1):135-6. Cancer Treat Rep. 1979. PMID: 369685 Clinical Trial. No abstract available.

9

Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer.

Yap HY, Benjamin RS, Blumenschein GR, Hortobagyi GN, Tashima CK, Buzdar AU, Bodey GP. Yap HY, et al. Among authors: hortobagyi gn. Cancer Treat Rep. 1979 Jan;63(1):77-83. Cancer Treat Rep. 1979. PMID: 369695 Clinical Trial.

10

Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.

Hortobagyi GN, Blumenschein GR, Tashima CK, Buzdar AU, Burgess MA, Livingston RB, Valdivieso M, Gutterman JU, Hersh EM, Bodey GP. Hortobagyi GN, et al. Cancer. 1979 Aug;44(2):398-405. doi: 10.1002/1097-0142(197908)44:2<398::aid-cncr2820440205>3.0.co;2-t. Cancer. 1979. PMID: 383255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,108 results

Search Page

Filters